novo nordisk ozempic wegovy news - Search News

Novo Nordisk, Wegovy

Wegovy sales are slaying for Novo Nordisk right now

Sales of Novo Nordisk’s (NVO) blockbuster weight loss drug Wegovy continue to soar, surpassing Wall Street expectations. The Danish pharma giant posted its third-quarter earnings report early Tuesday morning and boasted sales figures blowing past analysts’ projections.

CBS News on MSN · 4d

Ozempic, Wegovy sales inject wealth into Novo Nordisk home country of Denmark

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Bloomberg on MSN · 1d

Novo Nordisk’s Wegovy Sales Increase Reassures Investors

Novo Nordisk A/S shares rose as surging sales of the blockbuster weight-loss treatment Wegovy reassured investors after rival Eli Lilly & Co. reported disappointing sales of its obesity treatment last week.

Compounded Ozempic tied to deaths, hospitalizations

Medical Xpress · 14h

Novo Nordisk CEO warns of deaths linked to compounded semaglutide

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least 100 hospitalizations and 10 deaths.

Becker's Hospital Review · 13h

Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October requested the FDA block compounding pharmacies from producing versions of the drug, saying semaglutide is too complex for others to replicate safely.

Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief executive of Ozempic maker Novo Nordisk warned Wednesday.

4h

New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

4don MSN

Scientist behind Novo Nordisk's Ozempic, Wegovy started her career developing laundry detergent

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

1don MSN

Novo Nordisk shares jump 8% after Wegovy sales beat expectations

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations, said that its net profit in the ...

NBC Los Angeles1d

Novo Nordisk quarterly profit meets expectations as Wegovy maker narrows full-year guidance

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year ...

After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

1d

Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand

On Wednesday, Novo Nordisk A/S (NYSE:NVO) reported third-quarter 2024 sales of 71.311 billion Danish kroner (around $10.3 ...

1d

Novo Nordisk aware of 10 deaths related to weight-loss drug copies - report

Novo Nordisk (NVO) is aware of 10 deaths and 100 hospitalizations of people that took copycat versions of its popular drugs ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results